Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRA-ANALStandard

NITROGLYCERIN

NITROGLYCERIN

Standard Dose
0.4%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview NITROGLYCERIN is listed in Drugs@FDA under application 218756 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient NITROGLYCERIN Form and strength OINTMENT;INTRA-ANAL - 0.4% Sponsor SOLARIS PHARMA CORP Submission history Latest submission status date: 2025-12-18 00:00:00.

Structured Monograph

Clinical summary

Approval overview NITROGLYCERIN is listed in Drugs@FDA under application 218756 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient NITROGLYCERIN Form and strength OINTMENT;INTRA-ANAL - 0.4% Sponsor SOLARIS PHARMA CORP Submission history Latest submission status date: 2025-12-18 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.